TGTX : TG Therapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
year | Average | Low | High | Change from close on 2023-03-21 |
---|---|---|---|---|
2023 | $17.54 | $15.57 | $18.52 | 17.59% |
2024 | $17.39 | $15.16 | $18.48 | 16.55% |
2025 | $10.17 | $6.86 | $14.39 | -31.85% |
2026 | $6.46 | $6.16 | $6.7 | -56.71% |
2027 | $6.7 | $6.54 | $6.79 | -55.08% |
2028 | $4.83 | $2.75 | $6.46 | -67.65% |
2029 | $1.43 | $0.7 | $2.45 | -90.4% |
2030 | $0.67 | $0.56 | $0.92 | -95.53% |
2031 | $1.98 | $1.0 | $3.99 | -86.76% |
2032 | $9.73 | $4.89 | $13.05 | -34.82% |
2033 | $13.6 | $13.34 | $13.86 | -8.82% |
The 11 Wall Street analysts offering TG Therapeutics stock forecast in the last 6 months have average price target of
$18.27 with a high forecast of $25.0 and a low forecast of $6.0.
The average TG Therapeutics stock forecast represents a 22.45%
increase from the last price of $14.9200000762939.
From AI system, total return is 2366.52% from 4098 forecasts.
For TG Therapeutics stock forecast for 2023, 9 predictions are offered for each month of 2023 with average TG Therapeutics stock
forecast of $17.54, a high forecast of $18.52, and a low forecast of $15.57.
The average TG Therapeutics stock forecast 2023 represents a 17.59%
increase from the last price of $14.9200000762939.
For TG Therapeutics stock forecast for 2024, 12 predictions are offered for each month of 2024 with average TG Therapeutics stock
forecast of $17.39, a high forecast of $18.48, and a low forecast of $15.16.
The average TG Therapeutics stock forecast 2024 represents a 16.55%
increase from the last price of $14.9200000762939.
For TG Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average TG Therapeutics stock
forecast of $6.46, a high forecast of $6.7, and a low forecast of $6.16.
The average TG Therapeutics stock forecast 2026 represents a -56.71%
decrease from the last price of $14.9200000762939.
For TG Therapeutics stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average TG Therapeutics stock
forecast of $4.83, a high forecast of $6.46, and a low forecast of $2.75.
The average TG Therapeutics stock forecast 2028 represents a -67.65%
decrease from the last price of $14.9200000762939.
For TG Therapeutics stock forecast for 2031, 12 predictions are offered for each month of 2031 with average TG Therapeutics stock
forecast of $1.98, a high forecast of $3.99, and a low forecast of $1.0.
The average TG Therapeutics stock forecast 2031 represents a -86.76%
decrease from the last price of $14.9200000762939.
For TG Therapeutics stock forecast for 2033 (10 year), 3 predictions are offered for each month of 2033 with average TG Therapeutics stock
forecast of $13.6, a high forecast of $13.86, and a low forecast of $13.34.
The average TG Therapeutics stock forecast 2033 represents a -8.82%
decrease from the last price of $14.9200000762939.
Please, see more forecasts below.
TGTX : TG Therapeutics stock forecast by Wall Street Analysts
The average TG Therapeutics stock forecast from last 6 month is $18.27, and this show a 35.11% increase in average from the prior price target of the each prediction. Also, this average forecast of $18.27 represents a 32.39% increase from the past average forecast of $13.8, 6 months ago from 5 wall street analysts.
TG Therapeutics stock forecast for upcoming days
Date | Price Target | Change |
---|---|---|
2023-03-23 | $14.28 | -4.32% |
2023-03-24 | $13.96 | -2.18% |
2023-03-27 | $13.77 | -1.37% |
2023-03-28 | $13.51 | -1.94% |
2023-03-29 | $13.10 | -3.00% |
TGTX : Long term TG Therapeutics stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Apr. is $15.57 , for 2024 Mar. is $18.35 , for 2027 Mar. is $6.79 , for 2028 Mar. is $6.15 , for 2032 Mar. is $6.97 , and for 2033 Mar. is $13.86.
TGTX : TG Therapeutics stock forecast for 2023
Date | Price Target | Change |
---|---|---|
2023 Apr. | $15.57 | 4.34% |
2023 May. | $16.26 | 4.46% |
2023 Jun. | $16.92 | 4.04% |
2023 Jul. | $17.50 | 3.41% |
2023 Aug. | $17.95 | 2.57% |
2023 Sep. | $18.25 | 1.69% |
2023 Oct. | $18.42 | 0.95% |
2023 Nov. | $18.51 | 0.49% |
2023 Dec. | $18.52 | 0.04% |
TGTX : TG Therapeutics stock forecast for 2024
Date | Price Target | Change |
---|---|---|
2024 Jan. | $18.48 | -0.21% |
2024 Feb. | $18.42 | -0.32% |
2024 Mar. | $18.35 | -0.42% |
2024 Apr. | $18.24 | -0.57% |
2024 May. | $18.08 | -0.86% |
2024 Jun. | $17.88 | -1.12% |
2024 Jul. | $17.62 | -1.45% |
2024 Aug. | $17.29 | -1.88% |
2024 Sep. | $16.89 | -2.31% |
2024 Oct. | $16.41 | -2.84% |
2024 Nov. | $15.84 | -3.47% |
2024 Dec. | $15.16 | -4.31% |
TGTX : TG Therapeutics stock forecast for 2025
Date | Price Target | Change |
---|---|---|
2025 Jan. | $14.39 | -5.10% |
2025 Feb. | $13.55 | -5.82% |
2025 Mar. | $12.68 | -6.40% |
2025 Apr. | $11.80 | -6.98% |
2025 May. | $10.94 | -7.24% |
2025 Jun. | $10.15 | -7.22% |
2025 Jul. | $9.46 | -6.85% |
2025 Aug. | $8.84 | -6.56% |
2025 Sep. | $8.28 | -6.26% |
2025 Oct. | $7.77 | -6.20% |
2025 Nov. | $7.29 | -6.25% |
2025 Dec. | $6.86 | -5.78% |
TGTX : TG Therapeutics stock forecast for 2026
Date | Price Target | Change |
---|---|---|
2026 Jan. | $6.50 | -5.30% |
2026 Feb. | $6.16 | -5.26% |
2026 Mar. | $6.25 | 1.55% |
2026 Apr. | $6.26 | 0.10% |
2026 May. | $6.26 | 0.08% |
2026 Jun. | $6.31 | 0.70% |
2026 Jul. | $6.42 | 1.75% |
2026 Aug. | $6.57 | 2.29% |
2026 Sep. | $6.68 | 1.72% |
2026 Oct. | $6.70 | 0.39% |
2026 Nov. | $6.69 | -0.27% |
2026 Dec. | $6.70 | 0.16% |
TGTX : TG Therapeutics stock forecast for 2027
Date | Price Target | Change |
---|---|---|
2027 Jan. | $6.74 | 0.67% |
2027 Feb. | $6.78 | 0.59% |
2027 Mar. | $6.79 | 0.19% |
2027 Apr. | $6.79 | -0.11% |
2027 May. | $6.77 | -0.22% |
2027 Jun. | $6.74 | -0.46% |
2027 Jul. | $6.70 | -0.55% |
2027 Aug. | $6.67 | -0.44% |
2027 Sep. | $6.65 | -0.34% |
2027 Oct. | $6.63 | -0.36% |
2027 Nov. | $6.59 | -0.51% |
2027 Dec. | $6.54 | -0.78% |
TGTX : TG Therapeutics stock forecast for 2028
Date | Price Target | Change |
---|---|---|
2028 Jan. | $6.46 | -1.22% |
2028 Feb. | $6.34 | -1.93% |
2028 Mar. | $6.15 | -2.94% |
2028 Apr. | $5.90 | -4.16% |
2028 May. | $5.57 | -5.48% |
2028 Jun. | $5.19 | -6.82% |
2028 Jul. | $4.77 | -8.10% |
2028 Aug. | $4.33 | -9.23% |
2028 Sep. | $3.89 | -10.16% |
2028 Oct. | $3.47 | -10.77% |
2028 Nov. | $3.09 | -11.01% |
2028 Dec. | $2.75 | -11.00% |
TGTX : TG Therapeutics stock forecast for 2029
Date | Price Target | Change |
---|---|---|
2029 Jan. | $2.45 | -10.87% |
2029 Feb. | $2.19 | -10.69% |
2029 Mar. | $1.96 | -10.38% |
2029 Apr. | $1.77 | -9.93% |
2029 May. | $1.59 | -9.77% |
2029 Jun. | $1.43 | -10.13% |
2029 Jul. | $1.28 | -10.75% |
2029 Aug. | $1.13 | -11.34% |
2029 Sep. | $1.00 | -11.69% |
2029 Oct. | $.88 | -11.71% |
2029 Nov. | $.78 | -11.26% |
2029 Dec. | $.70 | -10.25% |
TGTX : TG Therapeutics stock forecast for 2030
Date | Price Target | Change |
---|---|---|
2030 Jan. | $.64 | -8.68% |
2030 Feb. | $.60 | -6.62% |
2030 Mar. | $.57 | -4.24% |
2030 Apr. | $.56 | -1.77% |
2030 May. | $.57 | 0.55% |
2030 Jun. | $.58 | 2.59% |
2030 Jul. | $.61 | 4.45% |
2030 Aug. | $.65 | 6.21% |
2030 Sep. | $.70 | 7.81% |
2030 Oct. | $.76 | 9.09% |
2030 Nov. | $.83 | 9.82% |
2030 Dec. | $.92 | 9.90% |
TGTX : TG Therapeutics stock forecast for 2031
Date | Price Target | Change |
---|---|---|
2031 Jan. | $1.00 | 9.45% |
2031 Feb. | $1.09 | 8.87% |
2031 Mar. | $1.19 | 8.67% |
2031 Apr. | $1.30 | 9.05% |
2031 May. | $1.42 | 9.93% |
2031 Jun. | $1.58 | 11.09% |
2031 Jul. | $1.78 | 12.35% |
2031 Aug. | $2.02 | 13.67% |
2031 Sep. | $2.33 | 15.18% |
2031 Oct. | $2.73 | 17.17% |
2031 Nov. | $3.27 | 19.81% |
2031 Dec. | $3.99 | 22.17% |
TGTX : TG Therapeutics stock forecast for 2032
Date | Price Target | Change |
---|---|---|
2032 Jan. | $4.89 | 22.57% |
2032 Feb. | $5.91 | 20.79% |
2032 Mar. | $6.97 | 17.92% |
2032 Apr. | $8.01 | 14.96% |
2032 May. | $8.99 | 12.23% |
2032 Jun. | $9.89 | 9.96% |
2032 Jul. | $10.68 | 8.00% |
2032 Aug. | $11.35 | 6.28% |
2032 Sep. | $11.90 | 4.85% |
2032 Oct. | $12.35 | 3.76% |
2032 Nov. | $12.72 | 3.04% |
2032 Dec. | $13.05 | 2.54% |
TGTX : TG Therapeutics stock forecast for 2033
Date | Price Target | Change |
---|---|---|
2033 Jan. | $13.34 | 2.27% |
2033 Feb. | $13.61 | 2.04% |
2033 Mar. | $13.86 | 1.80% |
Frequently Asked Questions about TG Therapeutics stock forecast
Is TG Therapeutics a good long term stock?
From TG Therapeutics stock forecast , TG Therapeutics (TGTX) stock can be a good investment choice. According to Tudal, the TG Therapeutics stock price forecast for 2023 Apr. is $15.5675208181407 From TG Therapeutics stock forecast , TG Therapeutics (TGTX) stock can be a good investment choice. According to Tudal, the TG Therapeutics stock price forecast for 2024 Mar. is $18.3458008550432 From TG Therapeutics stock forecast , TG Therapeutics (TGTX) stock cannot be a good investment choice. According to Tudal, the TG Therapeutics stock price forecast for 2027 Mar. is $6.79498058897929 From TG Therapeutics stock forecast , TG Therapeutics (TGTX) stock cannot be a good investment choice. According to Tudal, the TG Therapeutics stock price forecast for 2028 Mar. is $6.15188721268847 From TG Therapeutics stock forecast , TG Therapeutics (TGTX) stock cannot be a good investment choice. According to Tudal, the TG Therapeutics stock price forecast for 2032 Mar. is $6.96894968575544 From TG Therapeutics stock forecast , TG Therapeutics (TGTX) stock cannot be a good investment choice. According to Tudal, the TG Therapeutics stock price forecast for 2033 Mar. is $13.8589429210689
Is TG Therapeutics stock overvalued?
TG Therapeutics (TGTX) stock is expected to go UP . Therefore, Tudal would say that TG Therapeutics (TGTX) stock is NOT overvalued.
Will TG Therapeutics stock price go up?
Yes. The TG Therapeutics stock price forecast for 2024 Mar. is $18.3458008550432
Is TG Therapeutics stock a good buy now?
Since closing price on 2023-03-21 is $14.9200000762939 and forecast for 2024 Mar. is $18.35, TG Therapeutics stock is a good 1 year investment.